DBMG yields 3.63% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, DBMG + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DBMG + PFE for your $10,000?
DBM Global Inc., together with its subsidiaries, operates as steel fabrication and erection contractor in Canada, Australia, New Zealand, India, the Philippines, Thailand, the United Kingdom, and the United States. The company offers integrated structural and steel construction services; and professional services, including design-assist/design-build, pre-construction design and budgeting, steel management, fabrication, erection, and 3D building information modeling. It also fabricates trusses and girders; provides fabrication and erection of large-diameter water pipe and water storage tanks; provides integrated solutions for digital engineering, modeling and detailing, construction, and heavy equipment installation, as well as facility services, including maintenance, repair, and installation. In addition, the company manufactures pollution control scrubbers, tunnel liners, pressure vessels, strainers, filters, separators, and various customized products. It provides its services for projects in a range of markets that comprise commercial, industrial, and infrastructure construction projects, such as high- and low-rise buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills, and power plants. The company was formerly known as Schuff International, Inc. and changed its name to DBM Global Inc. in September 2016. DBM Global Inc. was incorporated in 2001 and is based in Phoenix, Arizona. DBM Global Inc. is a subsidiary of HC2 Holdings, Inc.
Full DBMG Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.